343 related articles for article (PubMed ID: 21752889)
21. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Janssen I; Chen CC; Millo CM; Ling A; Taieb D; Lin FI; Adams KT; Wolf KI; Herscovitch P; Fojo AT; Buchmann I; Kebebew E; Pacak K
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1784-91. PubMed ID: 26996779
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
[TBL] [Abstract][Full Text] [Related]
23.
Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
[TBL] [Abstract][Full Text] [Related]
24. Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A
Amodru V; Romanet P; Scemama U; Montava M; Fakhry N; Sebag F; Castinetti F; Lavieille JP; Loundou A; Varoquaux A; Barlier A; Pacak K; Taïeb D
Head Neck; 2019 Jun; 41(6):1565-1571. PubMed ID: 30584686
[TBL] [Abstract][Full Text] [Related]
25. 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Balogova S; Talbot JN; Nataf V; Michaud L; Huchet V; Kerrou K; Montravers F
Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):943-66. PubMed ID: 23417499
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma.
Ilias I; Chen CC; Carrasquillo JA; Whatley M; Ling A; Lazúrová I; Adams KT; Perera S; Pacak K
J Nucl Med; 2008 Oct; 49(10):1613-9. PubMed ID: 18794260
[TBL] [Abstract][Full Text] [Related]
27. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
28. Trimodal (18)F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier.
Treglia G; Ruberto T; Giovanella L
Endocrine; 2016 May; 52(2):397-8. PubMed ID: 25860886
[No Abstract] [Full Text] [Related]
29. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
30. Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [
Ohtake M; Tateishi K; Murata H; Nagashima Y; Yamanaka S; Yamamoto T
World Neurosurg; 2018 Jun; 114():47-52. PubMed ID: 29510284
[TBL] [Abstract][Full Text] [Related]
31. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
[TBL] [Abstract][Full Text] [Related]
32. Genetic status determines
Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
34. Compared to
Kroiss AS; Uprimny C; Shulkin BL; Frech A; Tilg H; Gasser RW; Sprinzl GM; Gruber L; Thomé C; Plangger C; Url C; Fraedrich G; Virgolini IJ
Ann Nucl Med; 2017 Jun; 31(5):357-365. PubMed ID: 28349331
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C
Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205
[TBL] [Abstract][Full Text] [Related]
36. Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A
Reichert T; Fakhry N; Lavieille JP; Amodru V; Sebag F; Romanet P; Loundou A; Castinetti F; Pacak K; Montava M; Taïeb D
Clin Endocrinol (Oxf); 2019 Dec; 91(6):879-884. PubMed ID: 31479526
[TBL] [Abstract][Full Text] [Related]
37. 68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.
Naji M; Zhao C; Welsh SJ; Meades R; Win Z; Ferrarese A; Tan T; Rubello D; Al-Nahhas A
Mol Imaging Biol; 2011 Aug; 13(4):769-75. PubMed ID: 20700766
[TBL] [Abstract][Full Text] [Related]
38. 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data.
Talbot JN; Kerrou K; Missoum F; Grahek D; Aide N; Lumbroso J; Montravers F
Mol Imaging Biol; 2005; 7(4):257-61. PubMed ID: 16082495
[TBL] [Abstract][Full Text] [Related]
39. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
Montravers F; Grahek D; Kerrou K; Ruszniewski P; de Beco V; Aide N; Gutman F; Grangé JD; Lotz JP; Talbot JN
J Nucl Med; 2006 Sep; 47(9):1455-62. PubMed ID: 16954553
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]